Table 1.
Clinical outcomes of RT for limited stage FL.
| Authors | Pts (n) | Total RT dose (Gy) | RT Volume | Follow-up yrs. | PFS (%) | OS (%) |
|---|---|---|---|---|---|---|
| Chen et al, 19793 | 26 | 35–45 | IF or EF | 6-yr 83 | NS | |
| Paryani et al, 19834 | 124 | 35–50 | IF,EF,TNI | 5,5 | 5-yr 62 10-yr 54 15-yr 42 |
5-yr 84 10-yr 68 15-yr 40 |
| Gospodarowicz et al, 19845 | 248 | 20–50 (<35 Gy in 86%) | IF | 12 | 5-yr 56 10-yr 53 |
5-yr 73 10-yr 58 |
| Epelbaum et al, 19926 | 48 | 30–50 | IF, EF | 6,3 | 5-yr 71 10-yr 57 |
5-yr 83 10-yr 68 |
| Vaughan Hudson et al, 19967 | 208 | 35 | NS | 10 | 10-yr 47 | 10-yr CSS 71–84 |
| Pendlebury et al, 19958 | 58 | 30–54 | IF,EF | NS | 5-yr 59 10-yr 43 |
5-yr 93 10-yr 79 |
| MacManus et al, 19969 | 177 | 35–44 | IF,EF,TNI | 7,7 | 5-yr 55 10-yr 44 15-yr 40 |
5-yr 82 10-yr 64 15-yr 44 |
| Stuschke et al, 199710 | 117 | 26 + 10 | EF,TNI | 5,7 | 5-yr 71 10-yr 59 |
5-yr 86 10-yr 86 |
| Kamath et al, 199911 | 72 | NS | IF,EF,TNI | NS | 5-yr 62 10-yr 59 15-yr 47 |
5-yr 73 10-yr 46 15-yr 40 |
| Wilder et al, 200112 | 80 | 26–50 | IF,EF | 19 | 5-yr 63 10-yr 57 15-yr 41 |
5-yr 82 10-yr 65 15-yr 43 |
| Ott et al, 200313 | 58 | 26–50 | IF,EF,TNI | 8,8 | 5-yr 74 10-yr 64 |
5-yr 86 10-yr 69 |
| Neumann et al, 200314 | 116 | 20–50 | IF,EF,TNI | 4 | 5-yr 62 10-yr 48 |
5-yr 76 10-yr 51 |
| Petersen et al, 200415 | 460 | 16–47.5 | IF | 12.5 | 5-yr 56 10-yr 41 |
5-yr 79 10-yr 62 |
| Eich et al, 200916 | 65 | 26–46 | IF,EF,TNI | 9.1 | 5-yr 55 10-yr 37 |
5-yr 86 10-yr 55 |
Abbreviations: IF (involved field); EF (extended field); TNI (total nodal irradiation); NS (not specified); CSS (cancer specific survival).